We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+19.61%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$2.63B
AUM Growth
+$411M
Cap. Flow
+$161M
Cap. Flow %
6.13%
Top 10 Hldgs %
44.92%
Holding
2,471
New
804
Increased
452
Reduced
440
Closed
595

Top Buys

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$13.4M
2
BOLD
Audentes Therapeutics, Inc
BOLD
+$10.5M
3
CISN
Cision Ltd. Ordinary Share
CISN
+$10M
4
MDCO
Medicines Co
MDCO
+$8.78M
5
TIF
Tiffany & Co.
TIF
+$7.91M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$42.5M
2
VSM
Versum Materials, Inc.
VSM
+$29.7M
3
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
+$23.3M
4
AABA
Altaba Inc
AABA
+$18.8M
5
CPE
Callon Petroleum Company
CPE
+$17.2M

Sector Composition

Rank Sector Weight
1 Technology 4.59%
2 Healthcare 3.78%
3 Consumer Discretionary 3.06%
4 Communication Services 2.48%
5 Real Estate 2.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SIEN
2326
DELISTED
Sientra, Inc.
SIEN
– –
-38,938
Closed -$2.52M
NEWR
2327
CALL
DELISTED
New Relic, Inc.
NEWR
– –
-4,500
Closed -$277K
ICPT
2328
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
– –
-151
Closed -$10K
LTRPA
2329
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
– –
-200
Closed -$2K
RAD
2330
CALL
DELISTED
Rite Aid Corporation
RAD
– –
-7,900
Closed -$55K
RAD
2331
PUT
DELISTED
Rite Aid Corporation
RAD
– –
-6,000
Closed -$42K
HARP
2332
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
– –
-20
Closed -$3K
KBAL
2333
DELISTED
Kimball International
KBAL
– –
-7,533
Closed -$145K
VNTR
2334
DELISTED
Venator Materials PLC
VNTR
– –
-33,099
Closed -$81K
MAXR
2335
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
– –
-9,430
Closed -$97.9K
BBBY
2336
CALL
DELISTED
Bed Bath & Beyond Inc
BBBY
– –
-8,900
Closed -$95K
BBBY
2337
PUT
DELISTED
Bed Bath & Beyond Inc
BBBY
– –
-97,300
Closed -$1.03M
ATCO
2338
PUT
DELISTED
Atlas Corp.
ATCO
– –
-20,000
Closed -$213K
OBSV
2339
DELISTED
ObsEva SA Ordinary Shares
OBSV
– –
-259
Closed -$2K
CAJ
2340
DELISTED
Canon, Inc.
CAJ
– –
-23,400
Closed -$625K
VIVO
2341
DELISTED
Meridian Bioscience Inc
VIVO
$0 ﹤0.01%
+23
New +$216
HTGM
2342
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
– –
-884
Closed -$106K
CYBE
2343
DELISTED
Cyberoptics Corp
CYBE
– –
-5,379
Closed -$77K
PING
2344
DELISTED
Ping Identity Holding Corp.
PING
– –
-324
Closed -$6K
GBT
2345
CALL
DELISTED
Global Blood Therapeutics, Inc.
GBT
– –
-100
Closed -$5K
TYME
2346
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
– –
-578
Closed -$1K
SNP
2347
DELISTED
CHINA PETROLEUM & CHEMICAL CORPORATION ADS (REP 100 ORDINARY H SHARES)
SNP
– –
-70,480
Closed -$4.14M
LFC
2348
DELISTED
China Life Insurance Company Ltd.
LFC
– –
-12,100
Closed -$139K
TUFN
2349
DELISTED
Tufin Software Technologies Ltd.
TUFN
– –
-32,172
Closed -$530K
TPTX
2350
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
– –
-11
Closed –
92 93
94
95 96

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q4 2019 Portfolio in Review

As of Q4 2019, Prelude Capital Management held 2,471 positions worth $2.63B, up 19% from $2.22B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Prelude Capital Management deployed $161M of net new capital in Q4 2019, opening 804 new positions and adding to 452 existing holdings. Its largest new stake was Netflix: 452,870 shares worth $14.7M.

By sector, the portfolio is most concentrated in Technology at 4.6% of assets, down from 6.3% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Callon Petroleum Company, an estimated $17.2M trimmed.

  • Prelude Capital Management's largest Q4 2019 buy was Netflix: 452,870 shares worth $14.7M.
  • Prelude Capital Management added most to Cision Ltd. Ordinary Share in Q4 2019, an estimated $10M increase.
  • Prelude Capital Management's biggest Q4 2019 reduction was Callon Petroleum Company, cutting an estimated $17.2M.
  • Prelude Capital Management fully exited Celgene Corp in Q4 2019, selling an estimated $42.5M.
  • Prelude Capital Management's ten largest holdings make up 45% of its $2.63B portfolio in Q4 2019.
  • Prelude Capital Management opened 804 new positions and closed 595 in Q4 2019.
  • Prelude Capital Management's portfolio value rose 19% quarter-over-quarter to $2.63B.

Based on Prelude Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.